XML 40 R27.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Statements of Operations-Additional Information (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2022
Statements of Operations-Additional Information |
Schedule of revenues disaggregated by major product category and geographic region | Net Sales by Product Type ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
For the Year Ended June 30 | ​ | 2022 | ​ | 2021 | ​ | 2020
Animal Health | ​ | ​ |  |  | ​ |  | ​ | ​ | ​
MFAs and other | ​ | $ | 361,538 | ​ | $ | 330,017 | ​ | $ | 322,300
Nutritional specialties | ​ |  | 157,196 | ​ |  | 142,760 | ​ | ​ | 129,264
Vaccines | ​ |  | 88,321 | ​ |  | 72,939 | ​ | ​ | 75,340
Total Animal Health | ​ | $ | 607,055 | ​ | $ | 545,716 | ​ | $ | 526,904
Mineral Nutrition | ​ |  | 259,512 | ​ |  | 220,560 | ​ | ​ | 214,412
Performance Products | ​ |  | 75,694 | ​ |  | 67,074 | ​ | ​ | 59,038
Total | ​ | $ | 942,261 | ​ | $ | 833,350 | ​ | $ | 800,354
​ Net Sales by Region ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
For the Year Ended June 30 | ​ | 2022 |  | 2021 |  | 2020
United States | ​ | $ | 561,803 | ​ | $ | 494,889 | ​ | $ | 471,938
Latin America and Canada | ​ |  | 191,047 | ​ |  | 166,325 | ​ | ​ | 158,939
Europe, Middle East and Africa | ​ |  | 122,480 | ​ |  | 114,131 | ​ | ​ | 112,179
Asia Pacific | ​ |  | 66,931 | ​ |  | 58,005 | ​ | ​ | 57,298
Total | ​ | $ | 942,261 | ​ | $ | 833,350 | ​ | $ | 800,354
​
Schedule of interest expense, net | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
For the Year Ended June 30 | ​ | 2022 |  | 2021 |  | 2020
Interest expense, net | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Term loan | ​ | $ | 8,962 | ​ | $ | 7,951 | ​ | $ | 7,751
Revolving credit facility | ​ |  | 2,956 | ​ |  | 3,649 | ​ |  | 5,317
Amortization of debt issuance costs | ​ |  | 590 | ​ |  | 833 | ​ |  | 882
Refinancing expense | ​ | ​ | — | ​ | ​ | 1,020 | ​ | ​ | —
Other | ​ |  | 183 | ​ |  | 265 | ​ |  | 663
Interest expense | ​ |  | 12,691 | ​ |  | 13,718 | ​ |  | 14,613
Interest income | ​ |  | (816) | ​ |  | (838) | ​ |  | (1,757)
​ | ​ | $ | 11,875 | ​ | $ | 12,880 | ​ | $ | 12,856
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​
Schedule of depreciation and amortization | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
For the Year Ended June 30 |  | 2022 |  | 2021 |  | 2020
Depreciation and amortization | ​ |  | ​ | ​ |  | ​ | ​ |  |
Depreciation of property, plant and equipment | ​ | $ | 23,781 | ​ | $ | 23,165 | ​ | $ | 23,250
Amortization of intangible assets | ​ |  | 8,924 | ​ |  | 8,715 | ​ |  | 8,869
Amortization of other assets | ​ |  | — | ​ |  | 5 | ​ |  | 222
​ | ​ | $ | 32,705 | ​ | $ | 31,885 | ​ | $ | 32,341
​
Schedule of amortization of intangible assets | ​
​ | ​ | ​ | ​
For the Year Ended June 30 |  | ​ |
2023 | ​ | $ | 9,614
2024 | ​ |  | 9,375
2025 | ​ |  | 7,769
2026 | ​ |  | 6,805
2027 | ​ |  | 6,556
Thereafter | ​ |  | 23,742
Total | ​ | $ | 63,861
​
Schedule of research and development expense | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
For the Year Ended June 30 |  | 2022 |  | 2021 |  | 2020
Research and development expense | ​ | $ | 20,832 | ​ | $ | 17,759 | ​ | $ | 13,738
​

X
- Definition Tabular disclosure of depreciation and amortization. + References No definition available. + Details
Name: | pahc_ScheduleOfDepreciationAndAmortizationTableTextBlock
Namespace Prefix: | pahc_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of interest expense, net. + References No definition available. + Details
Name: | pahc_ScheduleOfInterestExpenseNetTableTextBlock
Namespace Prefix: | pahc_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of research and development expense. + References No definition available. + Details
Name: | pahc_ScheduleOfResearchAndDevelopmentExpenseTableTextBlock
Namespace Prefix: | pahc_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_IncomeStatementRelatedDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 + Details
Name: | us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration